A clinical trial to study the effect of BALA (Sida Cordifolia) and VIDARIKAND (Puerariya Tuberosa) on KARSHYA W.S.R. to UNDERWEIGHT in CHILDRE
Phase 1
Not yet recruiting
- Conditions
- Health Condition 1: E45- Retarded development following protein-calorie malnutritionHealth Condition 2: E45- Retarded development following protein-calorie malnutrition
- Registration Number
- CTRI/2023/03/050823
- Lead Sponsor
- Government Ayurvedic College Patna Aryabhatta Knowledge University Patna Bihar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.The age group of patients will be between 05-16 years.
2.Patient will be underweight.
3.The sign and symptoms of Karshya(Underweight) based on both Ayurvedic as well as modern view.
Exclusion Criteria
1.Patient having age below 5 years and above 16 years.
2.Underweight having other severe illness.
3.Patient suffering from chronic disease like cancer, cardiac disorder, T.B. etc.
4.Patient having any kidney disease and any life threating disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in <br/ ><br>1.Emaciated buttock abdomen neck (Sushka, Sphiga, Udar, Griva). <br/ ><br>2.Prominent venous network (Dhamani jala Santato). <br/ ><br>3.Skin bone appearance (Twak Asthi Sesha). <br/ ><br>4.Prominent joint (Sthula Parva). <br/ ><br>5.Hunger, thirst, etc. <br/ ><br>Timepoint: 90 days
- Secondary Outcome Measures
Name Time Method Change in the quantitative (Anthropometric) variables i.e. <br/ ><br>1.Weight. <br/ ><br>2.Hight. <br/ ><br>3.Upper mid arm thickness. <br/ ><br>4.Mid-thigh thickness. <br/ ><br>5.BMI. etc. <br/ ><br>Timepoint: 90 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the therapeutic effects of Sida Cordifolia and Puerariya Tuberosa in protein-calorie malnutrition?
How does the combination of BALA and VIDARIKAND compare to standard nutritional interventions for underweight children in clinical efficacy?
Are there specific biomarkers that can predict response to Sida Cordifolia and Puerariya Tuberosa in pediatric protein-calorie malnutrition?
What are the potential adverse events associated with BALA and VIDARIKAND treatment in phase I trials for underweight children?
What is the evidence for herbal combinations targeting metabolic pathways in underweight children with protein-calorie malnutrition?